Functional genomics approaches to understanding brain disorders

Pharmacogenomics

Volumn 3, Issue 1, 2002, Pages 31-45

  Shilling, Paul D ^a   Kelsoe, John R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Brain disorders; cDNA arrays; Cell culture; Chemical mutagenesis; Data mining; Data sharing; DNA microarrays; Gene expression profiling; In situ hybridization; mRNA; Oligonucleotide arrays; Postmortem; Proteomics; Single nucleotide polymorphisms; Therapeutics; Transgenics

Indexed keywords

DNA; METHAMPHETAMINE; NEUROLEPTIC AGENT;

AUTOPSY; BRAIN DISEASE; BRAIN TISSUE; CELL CULTURE; CONTROLLED STUDY; DISEASE MODEL; DNA MICROARRAY; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TECHNOLOGY; GENETIC ANALYSIS; GENOME ANALYSIS; HUMAN; HUMAN GENOME; MEDICAL RESEARCH; NEUROSCIENCE; NONHUMAN; REVIEW; SEQUENCE ANALYSIS;

ANIMALS; BRAIN DISEASES; DNA, COMPLEMENTARY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOME; RNA, MESSENGER;

ANIMALIA;

EID: 0036211235     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.3.1.31     Document Type: Review

References (94)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Genomics, gene expression and DNA arrays
4. Identification and cloning of differentially expressed genes by long distance differential display
5. Serial analysis of gene expression
6. TOGA: An automated parsing technology for analyzing expression of nearly all genes
7. Implementation of a large-scale ENU mutagenesis program: Towards increasing the mouse mutant resource
8. Biomedical discovery with DNA arrays
9. mRNA in the mammalian central nervous system
10. High throughput analysis of gene expression in the human brain
11. Expressing what's on your mind: DNA arrays and the brain
12. Regional and strain-specific gene expression mapping in the adult mouse brain
13. Expression monitoring by hybridization to high-density oligonucleotide arrays
14. High density synthetic oligonucleotide arrays
15. Functional genomics
16. Exploring the metabolic and genetic control of gene expression on a genomic scale
17. Drug target validation and identification of secondary drug target effects using DNA microarrays
18. Mice, microarrays, and the genetic diversity of the brain
19. Microarray applications in neuroscience
20. DNA microarrays in neuropsychopharmacology
21. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression
22. Applications of biochip and microarray systems in pharmacogenomics
23. A concise guide to cDNA microarray analysis
24. Sensitivity issues in DNA array based expression measurements and performance of nylon microarrays for small samples
25. The future of genetic studies of complex human diseases
26. Population genetics-making sense out of sequence
27. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
28. Gene expression profiling: Monitoring transcription and translation products using DNA microarrays and proteomics
29. Proteomics: Can Celera do it again?
30. High resolution two-dimensional electrophoresis of proteins
31. Two-dimensional polyacrylamide gel electrophoretic fractionation
32. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals
33. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
34. Proteome and proteomics: New technologies, new concepts, and new words
35. Quantitative proteomics?
36. Functional genomics by mass spectrometry
37. Techniques editorial overview: Genome-wide approaches to cell function
38. Basic local alignment search tool
39. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
40. Basic microarray analysis: Grouping and feature reduction
41. Cluster analysis and display of genome-wide expression patterns
42. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
43. Analysis of gene expression data using self-organizing maps
44. Knowledge-based analysis of microarray gene expression data by using support vector machines
45. Analysis of large-scale gene expression data
46. Principal components analysis to summarize microarray experiments: Application to sporulation time series
47. Supervised harvesting of expression trees
48. 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns
49. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
50. Microarrays in brain research: The good, the bad and the ugly
51. Exploring the new world of the genome with DNA microarrays
52. Automatic classification of two-dimensional gel electrophoresis pictures by heuristic clustering analysis: A step toward machine learning
53. An information-intensive approach to the molecular pharmacology of cancer
54. Sharing gene expression data: An array of options
55. The sharing of cDNA microarray data
56. Microarrays: Lost in a storm of data?
57. Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse
58. Importance of replication in microarray gene expression studies: Statistical methods and evidence from repetitive cDNA hybridizations
59. Two intronic mutations in the adrenoleukodystrophy gene
60. Gene expression profiles of laser-captured adjacent neuronal subtypes
61. Pre- and postmortem influences on brain RNA
62. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium
63. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol
64. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum
65. Differential effects of acute and chronic treatment with typical and atypical neuroleptics on c-fos mRNA expression in rat forebrain regions using non-radioactive in situ hybridization
66. 5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs
67. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons
68. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays
69. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
70. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
71. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach
72. Gene-expression profile of the ageing brain in mice
73. Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases
74. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
75. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
76. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine
77. Analysis of oligodendroglial differentiation using cDNA arrays
78. A genetic analysis of neural progenitor differentiation
79. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior
80. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse
81. Optimizing the mouse to sift sequence for function
82. Recombinogenic targeting: A new approach to genomic analysis-a review
83. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories
84. Effects of environmental enrichment on gene expression in the brain
85. Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice
86. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: Implications for idiopathic Parkinson's disease
87. Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm
88. Insights from mouse models into the molecular basis of neurodegeneration
89. Phenotypic analysis-making the most of your mouse
90. Progress in the modeling of neurodegenerative diseases in transgenic mice
91. Genomic strategies to identify mammalian regulatory sequences
92. cDNA arrays in Neuroscience:nylon membrane based arrays
93. Information processing issues and solutions associated with microarray technology